Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "Mila"

660 News Found

Zymo Research donates one million Covid-19 test kits to Mapmygenome
News | September 28, 2021

Zymo Research donates one million Covid-19 test kits to Mapmygenome

Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries


PM Modi launches Ayushman Bharat Digital Mission
Public Health | September 27, 2021

PM Modi launches Ayushman Bharat Digital Mission

The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.


AstraZeneca to collaborate with VaxEquity for self-amplifying RNA therapy
Biotech | September 24, 2021

AstraZeneca to collaborate with VaxEquity for self-amplifying RNA therapy

saRNA is a new platform for the development of medicines and vaccines which uses similar technology to mRNA but with the added ability to self-amplify, thereby expressing proteins for longer, resulting in higher protein levels per dose level


Pfizer and BioNTech receive U.S. FDA EUA for Covid-19 booster
Drug Approval | September 23, 2021

Pfizer and BioNTech receive U.S. FDA EUA for Covid-19 booster

Emergency Use Authorisation (EUA) is granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups


UFlex joins Alliance in its mission to end plastic waste
Sustainability | September 23, 2021

UFlex joins Alliance in its mission to end plastic waste

UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste


Promising prospects for Indian pharma: CLSA
News | September 17, 2021

Promising prospects for Indian pharma: CLSA

CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report


Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis
Public Health | September 14, 2021

Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis

Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor


Navitas Life Sciences acquires its 200th customer
Digitisation | September 08, 2021

Navitas Life Sciences acquires its 200th customer

First launched in 2005, pharmaREADY is a fully integrated, regulatory compliant, web-based platform to create, view, and manage global regulatory submissions


HUL funds study on Covid-19 vulnerability and vaccine efficiency
News | September 07, 2021

HUL funds study on Covid-19 vulnerability and vaccine efficiency

The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.


DGCI approves Hetero’s Tocilizumab
Drug Approval | September 06, 2021

DGCI approves Hetero’s Tocilizumab

Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month